Baricitinib for the treatment of rheumatoid arthritis and systemic lupus erythematosus: a 2019 update
Kubo S;Nakayamada S;Tanaka Y;;
expert review of clinical immunology2019Vol. 15pp. -
246
s2019expertbaricitinib
Abstract
Introduction: JAK, which constitutively binds to some cytokine receptors, plays an important role in cytokine signaling. While JAK is comprised of JAK1, JAK2, JAK3, and Tyk2, more than 40 types of cytokines transmit signals through JAK. Baricitinib is reported to be highly effective in the tr …